U.S. markets open in 3 hours 40 minutes
  • S&P Futures

    -8.50 (-0.22%)
  • Dow Futures

    -110.00 (-0.36%)
  • Nasdaq Futures

    +55.75 (+0.41%)
  • Russell 2000 Futures

    -8.80 (-0.41%)
  • Crude Oil

    +0.37 (+0.70%)
  • Gold

    -6.60 (-0.36%)
  • Silver

    -0.15 (-0.60%)

    -0.0034 (-0.28%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    +1.08 (+4.66%)

    -0.0000 (-0.00%)

    +0.1340 (+0.13%)

    -374.35 (-1.18%)
  • CMC Crypto 200

    -11.19 (-1.75%)
  • FTSE 100

    -15.67 (-0.24%)
  • Nikkei 225

    +89.03 (+0.31%)

Insider Buying: The National Health Investors, Inc. (NYSE:NHI) Independent Director Just Bought US$332k Worth Of Shares

Simply Wall St
·3 min read

Potential National Health Investors, Inc. (NYSE:NHI) shareholders may wish to note that the Independent Director, Robert Adams, recently bought US$332k worth of stock, paying US$66.35 for each share. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.

See our latest analysis for National Health Investors

The Last 12 Months Of Insider Transactions At National Health Investors

The Chairman of the Board W. Adams made the biggest insider purchase in the last 12 months. That single transaction was for US$976k worth of shares at a price of US$36.16 each. Even though the purchase was made at a significantly lower price than the recent price (US$64.77), we still think insider buying is a positive. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.

In the last twelve months insiders purchased 37.05k shares for US$1.5m. But insiders sold 1.67k shares worth US$152k. In total, National Health Investors insiders bought more than they sold over the last year. Their average price was about US$41.25. It is certainly positive to see that insiders have invested their own money in the company. But we must note that the investments were made at well below today's share price. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!


There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership of National Health Investors

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. National Health Investors insiders own about US$123m worth of shares (which is 4.2% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Do The National Health Investors Insider Transactions Indicate?

It is good to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about National Health Investors. One for the watchlist, at least! While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. When we did our research, we found 2 warning signs for National Health Investors (1 is potentially serious!) that we believe deserve your full attention.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.